Icon (ICLR) Cash from Investing Activities (2009 - 2026)
Icon's (ICLR) quarterly Cash from Investing Activities came in at -$108.3 million in Q2 2026, down 183.54% year-over-year from $129.7 million in Q2 2025, and down 174.7% quarter-over-quarter from -$39.4 million in Q1 2026.
Analysis
Icon (ICLR) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Cash from Investing Activities for 18 consecutive years, with -$108.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 183.54% year-over-year to -$108.3 million in Q2 2026; TTM through Jun 2026 was -$259.8 million, a 3.31% increase from a year earlier, with the FY2025 full-year figure at -$187.5 million, up 29.71% from the prior year.
- Cash from Investing Activities was -$108.3 million for Q2 2026 at Icon, down from -$39.4 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$19.5 million in Q1 2022 and troughed at -$124.3 million in Q3 2024.
- A 5-year average of -$54.1 million and a median of -$39.4 million in 2024 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities surged 99.35% in 2022 and slumped 250.29% in 2024, its largest moves.
- Over 5 years, Cash from Investing Activities stood at -$58.9 million in 2022, then tumbled by 108.05% to -$122.5 million in 2023, then jumped by 43.77% to -$68.9 million in 2024, then climbed by 18.79% to -$55.9 million in 2025, then sank by 93.67% to -$108.3 million in 2026.
- The last three Cash from Investing Activities figures came in at -$108.3 million (Q2 2026), -$39.4 million (Q1 2026), and -$55.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -381.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -23.89 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -108.34 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 28.10 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -7.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 11.09 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -55,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -55,941.69 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -108.34 Mn |
| Mar 31, 2026 | -39.44 Mn |
| Dec 31, 2025 | -55.94 Mn |
| Sep 30, 2025 | -56.10 Mn |
| Jun 30, 2025 | -38.21 Mn |
| Mar 31, 2025 | -37.28 Mn |
| Dec 31, 2024 | -68.88 Mn |
| Sep 30, 2024 | -124.34 Mn |
| Jun 30, 2024 | -34.20 Mn |
| Mar 31, 2024 | -39.37 Mn |
| Dec 31, 2023 | -122.50 Mn |
| Sep 30, 2023 | -35.50 Mn |
| Jun 30, 2023 | -40.61 Mn |
| Mar 31, 2023 | -28.04 Mn |
| Dec 31, 2022 | -58.88 Mn |
| Sep 30, 2022 | -38.35 Mn |
| Jun 30, 2022 | -29.10 Mn |
| Mar 31, 2022 | -19.54 Mn |
| Dec 31, 2021 | -59.02 Mn |
| Sep 30, 2021 | -5.94 Bn |